Several phase II/III trials show safety and efficacy of fingolimod in relapsing-remitting MS Nov. 9, 2010
Intranasal GI.1 norovirus virus-like particle vaccine is safe and efficacious in healthy volunteers Nov. 8, 2010
MLN-8237 shows promise in epithelial ovarian, fallopian tube and primary peritoneal carcinoma Nov. 5, 2010
Lucinactant receives FDA orphan drug status in CF after encouraging phase II trial results Nov. 5, 2010
RSS